Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Radical cure of experimental babesiosis in immunodeficient mice using a combination of an endochin-like quinolone and atovaquone.

Lawres LA, Garg A, Kumar V, Bruzual I, Forquer IP, Renard I, Virji AZ, Boulard P, Rodriguez EX, Allen AJ, Pou S, Wegmann KW, Winter RW, Nilsen A, Mao J, Preston DA, Belperron AA, Bockenstedt LK, Hinrichs DJ, Riscoe MK, Doggett JS, Ben Mamoun C.

J Exp Med. 2016 Jun 27;213(7):1307-18. doi: 10.1084/jem.20151519. Epub 2016 Jun 6.

2.

Antibiotic susceptibilities among recent clinical isolates of Haemophilus influenzae and Moraxella catarrhalis from fifteen countries.

Bandak SI, Turnak MR, Allen BS, Bolzon LD, Preston DA, Bouchillon SK, Hoban DJ.

Eur J Clin Microbiol Infect Dis. 2001 Jan;20(1):55-60.

PMID:
11245326
3.

Oral antimicrobial susceptibilities of Streptococcus pyogenes recently isolated in five countries.

Bandak SI, Turnak MR, Allen BS, Bolzon LD, Preston DA.

Int J Clin Pract. 2000 Nov;54(9):585-8.

PMID:
11220986
4.

Assumed versus approved breakpoints.

Preston DA, Turnak MR.

Antimicrob Agents Chemother. 2000 Nov;44(11):3243-5. No abstract available.

5.

Assessment of the susceptibility of Streptococcus pneumoniae to cefaclor and loracarbef in 13 countries.

Bandak SI, Turnak MR, Allen BS, Bolzon LD, Preston DA.

J Chemother. 2000 Aug;12(4):299-305.

PMID:
10949979
6.
7.

Interpretation of pneumococcal susceptibility tests with cefaclor.

Preston DA.

J Clin Microbiol. 1999 Jun;37(6):2115. No abstract available.

8.

Cefaclor: a contemporary look at susceptibility of key pathogens from around the globe.

Preston DA, Turik M.

J Chemother. 1998 Jun;10(3):195-202.

PMID:
9669643
9.

Semisynthetic glycopeptide antibiotics derived from LY264826 active against vancomycin-resistant enterococci.

Nicas TI, Mullen DL, Flokowitsch JE, Preston DA, Snyder NJ, Zweifel MJ, Wilkie SC, Rodriguez MJ, Thompson RC, Cooper RD.

Antimicrob Agents Chemother. 1996 Sep;40(9):2194-9.

10.

Activities of the semisynthetic glycopeptide LY191145 against vancomycin-resistant enterococci and other gram-positive bacteria.

Nicas TI, Mullen DL, Flokowitsch JE, Preston DA, Snyder NJ, Stratford RE, Cooper RD.

Antimicrob Agents Chemother. 1995 Nov;39(11):2585-7. Erratum in: Antimicrob Agents Chemother 1996 May;40(5):1330.

11.

Antimicrobial characterization and interrelationships of dirithromycin and epidirithromycin.

Kirst HA, Creemer LC, Paschal JW, Preston DA, Alborn WE Jr, Counter FT, Amos JG, Clemens RL, Sullivan KA, Greene JM.

Antimicrob Agents Chemother. 1995 Jul;39(7):1436-41.

12.

Site-directed mutagenesis of the mecA gene from a methicillin-resistant strain of Staphylococcus aureus.

Wu CY, Alborn WE Jr, Flokowitsch JE, Hoskins J, Unal S, Blaszczak LC, Preston DA, Skatrud PL.

J Bacteriol. 1994 Jan;176(2):443-9.

13.

Discovery and structure-activity relationship of a series of 1-carba-1-dethiacephems exhibiting activity against methicillin-resistant Staphylococcus aureus.

Ternansky RJ, Draheim SE, Pike AJ, Bell FW, West SJ, Jordan CL, Wu CY, Preston DA, Albron W Jr, Kasher JS, et al.

J Med Chem. 1993 Jul 9;36(14):1971-6.

PMID:
8336336
14.

In-vitro synergy and mechanism of interaction between vancomycin and ciprofloxacin against enterococcal isolates.

Unal S, Flokowitsch J, Mullen DL, Preston DA, Nicas TI.

J Antimicrob Chemother. 1993 May;31(5):711-23.

PMID:
8335499
15.

Global surveillance of bacterial susceptibility to cefaclor: 1988-1990.

Preston DA.

Clin Ther. 1993 Jan-Feb;15(1):88-96.

PMID:
8458058
16.

Detection of methicillin-resistant staphylococci by using the polymerase chain reaction.

Unal S, Hoskins J, Flokowitsch JE, Wu CY, Preston DA, Skatrud PL.

J Clin Microbiol. 1992 Jul;30(7):1685-91.

17.

Construction of a water-soluble form of penicillin-binding protein 2a from a methicillin-resistant Staphylococcus aureus isolate.

Wu CY, Hoskins J, Blaszczak LC, Preston DA, Skatrud PL.

Antimicrob Agents Chemother. 1992 Mar;36(3):533-9.

18.

Daptomycin disrupts membrane potential in growing Staphylococcus aureus.

Alborn WE Jr, Allen NE, Preston DA.

Antimicrob Agents Chemother. 1991 Nov;35(11):2282-7.

19.

Synthesis and antimicrobial evaluation of dirithromycin (AS-E 136; LY237216), a new macrolide antibiotic derived from erythromycin.

Counter FT, Ensminger PW, Preston DA, Wu CY, Greene JM, Felty-Duckworth AM, Paschal JW, Kirst HA.

Antimicrob Agents Chemother. 1991 Jun;35(6):1116-26.

20.

Synthesis, hydrolysis rates, supercomputer modeling, and antibacterial activity of bicyclic tetrahydropyridazinones.

Jungheim LN, Boyd DB, Indelicato JM, Pasini CE, Preston DA, Alborn WE Jr.

J Med Chem. 1991 May;34(5):1732-9.

PMID:
2033596
21.

A54145 a new lipopeptide antibiotic complex: microbiological evaluation.

Counter FT, Allen NE, Fukuda DS, Hobbs JN, Ott J, Ensminger PW, Mynderse JS, Preston DA, Wu CY.

J Antibiot (Tokyo). 1990 Jun;43(6):616-22.

22.

Biological characterization of a new radioactive labeling reagent for bacterial penicillin-binding proteins.

Preston DA, Wu CY, Blaszczak LC, Seitz DE, Halligan NG.

Antimicrob Agents Chemother. 1990 May;34(5):718-21.

23.

Antibacterial properties of the bicyclic pyrazolidinones.

Allen NE, Hobbs JN Jr, Preston DA, Turner JR, Wu CY.

J Antibiot (Tokyo). 1990 Jan;43(1):92-9.

24.

3-Quaternary ammonium 1-carba-1-dethiacephems.

Cook GK, McDonald JH 3rd, Alborn W Jr, Boyd DB, Eudaly JA, Indelicato JM, Johnson R, Kasher JS, Pasini CE, Preston DA, et al.

J Med Chem. 1989 Nov;32(11):2442-50.

PMID:
2810333
25.

Activity of glycopeptides against vancomycin-resistant gram-positive bacteria.

Nicas TI, Cole CT, Preston DA, Schabel AA, Nagarajan R.

Antimicrob Agents Chemother. 1989 Sep;33(9):1477-81.

26.

Characterization of vancomycin resistance in Enterococcus faecium and Enterococcus faecalis.

Nicas TI, Wu CY, Hobbs JN Jr, Preston DA, Allen NE.

Antimicrob Agents Chemother. 1989 Jul;33(7):1121-4.

27.

National collaborative study of the prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae.

Doern GV, Jorgensen JH, Thornsberry C, Preston DA, Tubert T, Redding JS, Maher LA.

Antimicrob Agents Chemother. 1988 Feb;32(2):180-5.

28.

Susceptibility of multiply resistant Haemophilus influenzae to newer antimicrobial agents.

Jorgensen JH, Doern GV, Thornsberry C, Preston DA, Redding JS, Maher LA, Tubert T.

Diagn Microbiol Infect Dis. 1988 Jan;9(1):27-32.

PMID:
3259490
29.

Prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae: a collaborative study.

Doern GV, Jorgensen JH, Thornsberry C, Preston DA.

Diagn Microbiol Infect Dis. 1986 Feb;4(2):95-107.

PMID:
3485505
30.

Microbiological aspects of erythromycin.

Preston DA.

Pediatr Infect Dis. 1986 Jan-Feb;5(1):120-3.

PMID:
3003714
31.

Effect of refrigerated storage on cefaclor in Mueller-Hinton agar.

Surprenant AM, Preston DA.

J Clin Microbiol. 1985 Jan;21(1):133-4.

33.

Quality control of moxalactam susceptibility disks.

Barry AL, Preston DA, Jones RN, Gavan TL, Thornsberry C.

J Clin Microbiol. 1983 Jun;17(6):1032-8.

34.

The antimicrobial activity of cephalexin against old and new pathogens.

Jones RN, Preston DA.

Postgrad Med J. 1983;59 Suppl 5:9-15. Review.

PMID:
6364091
36.
38.

Alcohol consumption and the incidence of violent crime.

Gerson LW, Preston DA.

J Stud Alcohol. 1979 Mar;40(3):307-12.

PMID:
449349
39.

Summary of laboratory studies on the antibacterial activity of cefaclor.

Preston DA.

Postgrad Med J. 1979;55 Suppl 4:22-9.

PMID:
398479
40.
41.

Delineation of the relative antibacterial activity of cefamandole and cefamandole nafate.

Turner JR, Preston DA, Wold JS.

Antimicrob Agents Chemother. 1977 Jul;12(1):67-72.

42.

The health expenditure problem in New Zealand.

Preston DA.

N Z Med J. 1977 Jun 8;85(589):480-3. No abstract available.

PMID:
414180
44.
45.

[Characteristics of the rural emigration in the Ecuadorian Sierra].

Preston DA, Taveras GA.

Rev Geogr Inst Panam Geogr Hist. 1976;(84):23-31. Spanish. No abstract available.

PMID:
12178403
46.

Rapid detection of ampicillin-resistant Haemophilus influenzae and their susceptibility to sixteen antibiotics.

Kammer RB, Preston DA, Turner JR, Hawley LC.

Antimicrob Agents Chemother. 1975 Jul;8(1):91-4.

47.

Compound 64716, a new synthetic antibacterial agent.

Wick WE, Preston DA, White WA, Gordee RS.

Antimicrob Agents Chemother. 1973 Oct;4(4):415-20.

48.

New synthetic antibacterial compound, 1-(2-hydroxyethyl)-3-nitro-4-pyrazole carboxamide.

Wick WE, Preston DA, Terando NH, Welles JS, Gordee RS.

Antimicrob Agents Chemother. 1973 Sep;4(3):343-5.

49.

Biological properties of three 3-heterocyclic-thiomethyl cephalosporin antibiotics.

Wick WE, Preston DA.

Antimicrob Agents Chemother. 1972 Mar;1(3):221-34.

Supplemental Content

Loading ...
Support Center